Our results showed that MMP-2, MMP-7, and TIMP-2 levels did not change statistically significantly before and during the treatment of ALL patients, although MMP-2 levels at day 0 and day 33 correlate with the initial blastosis in the bone marrow. Here, TIMP2 is linked to acute lymphoblastic leukemia.